A catheter connector device for connecting a syringe or other fluid application and/or removal device, and a catheter is provided comprising a port for receiving a catheter, a port for connecting a syringe or other fluid application and/or removal device, and a push-button for securing the received catheter. The push-button includes internal arms embracing internal cantilevered structures in turn embracing a flexible tubular sleeve into which the catheter is inserted; when the push-button is pushed to an inward position, the arms of the push-button apply a pressure on the cantilevered structures, and thus on the tubular sleeve, gripping the catheter.

A venous access port assembly having a base, a peripheral surface, and a septum. The base defines an interior reservoir. The peripheral surface includes integrally molded X-ray discernable indicia identifying that the assembly is rated for power injection. The X-ray discernable indicia may extend through a height of the peripheral surface from a top surface to a bottom surface thereof. According to one aspect, the peripheral surface may be formed from X-ray discernable material, and the X-ray discernable indicia may be formed from the X-ray discernable material, or they may be formed by voids in the X-ray discernable material. According to another aspect, the peripheral surface may be formed from a radiotransparent or radiolucent material and applied with a radiopaque agent, and the X-ray discernable indicia may be one or more voids in the radiopaque agent or may be portions of the peripheral surface applied with the radiopaque agent.

A medical device is provided which comprises an implantable vascular access port including a fluid passage operable to introduce fluid to a host and/or remove fluid from the host, the fluid passage accessible through a fluid passage access opening and at least a portion of the fluid passage defined by a needle configured to penetrate cutaneous tissue of the host; and an implantable vascular access catheter connectable with the vascular access port; wherein the vascular access catheter and the vascular access port are connectable to each other within the vascular access port.

An injection port dressing assembly for covering an injection port in a patient includes a dressing that is positionable around an injection port in a patient to inhibit bacteria from accessing the injection port. The dressing has a tube opening therein to accommodate an injection tube from the injection port. A dome is provided and the dome is coupled to the dressing to cover the injection port when the dressing is placed on the patient. The dome is comprised of a translucent material to facilitate the injection port to be visible through the dome. An adhesive layer is coupled to the dressing to adhesively engage the patient's skin.

A carrier device and methods of use are described. The device and methods are directed toward implanting in biological tissue and for releasing a medical payload or functional material in biological tissue according to a remote magnetic trigger. The carrier device has a cavity with an opening through an external surface of the device. The carrier device includes at least one moveable, magnetic element sensitive to a magnetic field gradient. When a magnetic field gradient, rotating magnetic field, or uniform magnetic field, or a combination of thereof is applied to the tissue, the moveable magnetic element provides release of the medical payload or functional material through the cavity opening. In some embodiments, payload release can be started, stopped, and restarted at a later time or place. In addition to payload release, devices of this invention are equipped with a propelling element, the propelling element is responsive to external stimuli that enables propulsion and navigation of the device.

A system for delivering fluid to a user transcutaneously includes a torsion spring, a drive wheel, a linear slide having a stylet attached thereto, and a cannula. The torsion spring, when actuated, is configured to rotate the drive wheel to cause the linear slide to move axially to drive the stylet and cannula into a user-s skin.

A device is provided for shielding a fluid access port structure that is located along tubing that is part of an intravenous (IV) medication delivery system and is configured to permit injection of a fluid into the tubing. The device includes a body having a hollow interior and a first opening formed therein for receiving the fluid access port structure such that a side wall of the body surrounds and extends above the fluid access port structure. The body also includes a second opening through which a fluid delivery member can be inserted to allow mating between the fluid delivery member and the fluid access port structure for delivering the fluid into the tubing.

Proposed is a stopcock that enables natural injection of a drug and prevents backflow of a drug injected in another direction on a body. The stopcock includes: a body formed in a passage shape connecting a drug solution injection pipe and a supply pipe to each other; and a backflow prevention unit having a first end coupled to a side of the body between the drug solution injection pipe and the supply pipe and a second end extending toward an inside of the body to isolate the drug solution injection pipe and the supply pipe from each other, in which the second end of the backflow prevention unit bends toward the inside of the body and guides movement of a drug when the drug is injected through the drug solution injection pipe, and elastically moves to an initial position when injection of the drug is stopped.

The invention pertains to apparatuses, means and methods to promote uptake of biocompatible fluids into a reservoir of an implantable drug delivery system though a porous membrane. Embodiments of the invention promote fluid uptake by creating a pressure differential between the reservoir of the drug delivery device and the biocompatible fluid outside the device.

The METHODS, APPARATUSES AND SYSTEMS FOR INSTILLING STEM CELLS AND PHARMACEUTICALS INTO THE HUMAN VENTRICULAR SYSTEM (hereinafter “Ventricular Stem Cell System” or “VSCS”) disclosed herein provide safe and effective techniques for obtaining stem cells and instilling any type of stem cell or pharmaceutical agents into the human ventricular system for treatment of various diseases, including neurodegenerative diseases such as Parkinson's, Alzheimer's, Multiple Sclerosis, and others.